BioNexus Gene Lab (BGLC) Total Non-Current Liabilities (2018 - 2026)
BioNexus Gene Lab (BGLC) reported Total Non-Current Liabilities of $150407.0 for Q1 2026, up 1.67% on a YoY basis from $147940.0 in Q1 2025, and up 28.66% sequentially from $116899.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of Total Non-Current Liabilities data on file, last reported at $150407.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 1.67% year-over-year to $150407.0; the trailing twelve-month figure through Mar 2026 stood at $150407.0 (up 1.67% YoY), and the FY2025 full-year result was $116899.0, down 26.82% from the prior year.
- Total Non-Current Liabilities grew to $150407.0 in Q1 2026, from $116899.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $194615.0 in Q2 2024 to a low of $39659.0 in Q3 2022.
- A 5-year average of $112847.9 and a median of $116899.0 in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 237.24% in 2023 and tumbled 33.89% in 2025, its largest moves.
- Tracing BGLC's Total Non-Current Liabilities over 5 years: stood at $71072.0 in 2022, then soared by 56.2% to $111018.0 in 2023, then soared by 43.89% to $159741.0 in 2024, then retreated by 26.82% to $116899.0 in 2025, then climbed by 28.66% to $150407.0 in 2026.
- Business Quant data shows BGLC's Total Non-Current Liabilities at $150407.0 in Q1 2026, $116899.0 in Q4 2025, and $126943.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 35.25 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | 23.79 Bn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | 14.37 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | 19.98 Bn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | 13.25 Bn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | 32.26 Bn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | 5.04 Bn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 7.35 Bn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | 5.24 Bn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | 150,407.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,407.00 |
| Dec 31, 2025 | 116,899.00 |
| Sep 30, 2025 | 126,943.00 |
| Jun 30, 2025 | 141,347.00 |
| Mar 31, 2025 | 147,940.00 |
| Dec 31, 2024 | 159,741.00 |
| Sep 30, 2024 | 192,013.00 |
| Jun 30, 2024 | 194,615.00 |
| Mar 31, 2024 | 100,762.00 |
| Dec 31, 2023 | 111,018.00 |
| Sep 30, 2023 | 133,747.00 |
| Jun 30, 2023 | 58,705.00 |
| Mar 31, 2023 | 66,354.00 |
| Dec 31, 2022 | 71,072.00 |
| Sep 30, 2022 | 39,659.00 |
| Jun 30, 2022 | 44,542.00 |
| Mar 31, 2022 | 62,650.00 |
| Dec 31, 2021 | 65,856.00 |
| Sep 30, 2021 | 48,575.00 |
| Jun 30, 2021 | 59,106.00 |